AtriCure Files 8-K on Financial Results and Operations
Ticker: ATRC · Form: 8-K · Filed: Feb 15, 2024 · CIK: 1323885
Sentiment: neutral
Topics: financial-results, 8-K-filing, corporate-filing
Related Tickers: ATRC
TL;DR
**AtriCure just filed an 8-K detailing its financial results and operations, a standard update for investors.**
AI Summary
AtriCure, Inc. filed an 8-K on February 15, 2024, to report its results of operations and financial condition, along with related financial statements and exhibits. This filing, under SEC File Number 000-51470, indicates a routine disclosure of the company's financial performance. The document was filed from its business address at 7555 Innovation Way, Mason, OH 45040.
Why It Matters
This filing provides investors with an update on AtriCure's financial performance and operational status, which is crucial for evaluating the company's health and future prospects.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results and operations, without any indication of unusual or negative events within the provided text.
Key Players & Entities
- AtriCure, Inc. (company) — registrant
- February 15, 2024 (date) — date of earliest event reported
- Delaware (location) — state of incorporation
- 7555 Innovation Way, Mason OH 45040 (location) — principal executive offices
FAQ
What company filed this 8-K?
AtriCure, Inc. filed this 8-K.
What was the date of the earliest event reported in this filing?
The date of the earliest event reported was February 15, 2024.
What items were reported in this 8-K filing?
The 8-K reported on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
What is the state of incorporation for AtriCure, Inc.?
AtriCure, Inc. is incorporated in Delaware.
What is the business address of AtriCure, Inc. as listed in the filing?
The business address of AtriCure, Inc. is 7555 Innovation Way, Mason OH 45040.
Filing Stats: 582 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2024-02-15 16:00:37
Filing Documents
- atrc-20240215.htm (8-K) — 27KB
- atrc-20240215xexx991.htm (EX-99.1) — 152KB
- image_0.jpg (GRAPHIC) — 3KB
- 0001323885-24-000013.txt ( ) — 318KB
- atrc-20240215.xsd (EX-101.SCH) — 2KB
- atrc-20240215_lab.xml (EX-101.LAB) — 23KB
- atrc-20240215_pre.xml (EX-101.PRE) — 12KB
- atrc-20240215_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 15, 2024 , AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended December 31, 2023. The Company will hold a conference call on February 15, 2024 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated February 15, 2024, relating to financial results for the fourth quarter and full year ended December 31, 2023. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: February 15, 2024 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer